Zhengzhou Shunming TCM Institute for Hemopathy, approved jointly by government departments of hygiene, industrial and commercial, science and technology, and medical insurance, is a high-tech traditional Chinese medicine and pharmacy research and clinical medical institution comprising medical treatment, scientific research, development and application. The topics including leukemia, cancers and other difficult and complicated diseases, with purpose of healing the wounded and rescuing the dying as well as principle of regarding patients as their family members.
    Our Hospital and Institute locates at No. 95, Hongjun Street---east to the Post Building in Shijiazhuang North Railway Station. The six-floor clinic building covers an area of 2,500 square meters. We have solid technical force, with 56 employees and 10 of them have college degree or above, 9 of them have senior titles, 12 attending physicians, 6 physicians, 15 nurses and 8 medical technicians.
    Equipments: traditional Chinese and western medicine clinic, special clinic, inpatient department, emergency room, traditional Chinese and western medicine pharmacy, scientific research room, B-ultrasonic and color ultrasonic room, electrocardiographic room, laboratory, radiology department, Ear-point Inspection Room for common diseases of DCL---4MZ tumor and meeting room. We have complete equipments and establish assistant relations with several universities, hospitals and scientific research institutes, and they send professors and specialists to the Hospital and Institute to instruct our work.
    In order to overcome leukemia and cancer, under leadership of Institute director Wen Shunming, our Institute researches the unique treatment method, that is, traditional Chinese medicine-based with the principle of integration of traditional Chinese medicine with western medicine.
    Huaxia Traditional Chinese Medicine Institute for Leukemia takes the hemopathy research as topic, has explored the mystery of treatment of leukemia, selected more than one hundred kinds of natural and precious Chinese traditional and herbal drugs as raw materials with special processing and scientific synergy, integrated secret recipe with modern medicine, and researched and prepared the unique and effective “Xuefukang” serial prescriptions. We realized the ideal effects of curing hemopathy without blood transfusion, chemotherapy or bone marrow transplantation. The research achievements of “Xuefukang” medicines have passed evaluation of specialists and once awarded the golden prize of China International Medicine & Health Products Exposition in 1995. The “Clinical Research of Wen’s Decoction for Acute Leukemia” has been awarded the second prize of Science and Technology Progress Award of Zhengzhou as well as the first prize of Science and Technology Progress Award of Zhongyuan District of Zhengzhou. The patent No. of “Wen’s Decoction for Acute Leukemia” is 96118611.9. The scientific research achievements also attract attentions of more than ten news medium like Guangming Daily, China Youth Daily, Shanxi Daily, Tianjin Health Care Weekly and Harbin Senior Post and they have made special report on the medicine. The advent of “Wen’s Decoction for Acute Leukemia” creates the treatment of Leukemia by methods of traditional Chinese medicine and further enlightens the medical specialists to explore the new ideas of treating leukemia by combination of traditional Chinese medicine and Western medicine. Such creative outstanding contribution would propel the development of human medical culture positively.
    Basing on that the pure traditional Chinese medical preparations “Wen’s Decoction for Acute Leukemia” have good effects, in order to treat the complications caused by leukemia and side effects caused by chemotherapy, our Institute also researches the following medicines: the “Xuefukang” for treating serious anemia, “Shanhaijin” used for treating nausea and vomiting and anorexia caused by deficiency of spleen and stomach, the “Tongxinkang” used for treating cardiac insufficiency, “Fengshikang” used for treating arthralgia caused by leukemia, “Tangniaokang” used for treating elderly leukemia and diabetes, “Kechuankang” used for treating pulmonary infection caused by leukemia chemotherapy, “Kuiyangling” used for treating oral ulcer caused by chemotherapy, as well as “Xiaozhongzhitong Tincture” that is the external liniment used for treating redness and swelling of joints and lymph node swelling. The product does not only apply to the leukemia patient, but also have good effects in treating common diseases and frequently-occurring diseases.
    Our Institute develops new products continuously by cooperating with Beijing, Thailand, Vietnam, and Hong Kong, establishes clinical research bases in Beijing, Xi’an and Zhengzhou, and alleviates diseases conditions of thousands of patients completely.